SenzaGen
  • Home
  • Services
    • GARD: Sensitization Testing
    • Regulatory Toxicity Testing
    • Medical Device Services
    • Toxicology Advisory
    • Difficult-to-test
    • Who we work with
  • Science
    • GARD Technology
    • Science Behind
    • Scientific Publications
    • Posters
    • Webinars
  • Company
    • About Us
    • Sustainability
    • Career
    • Partners
  • Investors
    • SenzaGen at a Glance
    • Financial Reports
    • Press Releases
    • The Share
    • Analyst Coverage
    • Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Auditor
      • Nomination Committee
      • Annual General Meeting
    • Calendar
    • Prospekt / Emission
  • News and Events
    • Press Releases
    • News Posts
    • Event Calendar
  • Contact
  • Get a quote
  • Search
  • Menu Menu

SenzaGen’s Newsletter Dec 2022

19 December, 2022

Click image to view the newsletter in browser.

 

Share this entry
  • Share on Facebook
  • Share on X
  • Share on WhatsApp
  • Share on LinkedIn
  • Share on Vk
  • Share on Reddit
  • Share by Mail
https://senzagen.extendio.se/wp-content/uploads/2020/07/News.png 133 146 Tina Dackemark Lawesson https://senzagen.extendio.se/wp-content/uploads/2017/01/LoggaSquare_RGB_liten_HF.png Tina Dackemark Lawesson2022-12-19 11:21:582022-12-19 11:21:58SenzaGen’s Newsletter Dec 2022

Quick Links

Contact
Privacy Policy (En)
Privacy Policy (Sv)
General Terms and Conditions

Pages

  • Home
  • Services
  • Investors
  • Contact
  • News and Events

Follow Us

SUBSCRIBE TO PRESS RELEASES

Driving innovation and serving industry end-to-end

From innovative sensitization testing with GARD® to biological evaluation of Medical Devices, we offer both standard regulatory toxicity assessments and customized studies.

SenzaGen has acquired ToxHub to strengthen toxicology offeringJoint poster with ExxonMobil: Case study on UVCBs and Formulated Lubricant ...
Scroll to top

Subscribe


Prenumerera